These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32294308)
1. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. PelvEx Collaborative Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308 [TBL] [Abstract][Full Text] [Related]
2. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration. PelvEx Collaborative Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268 [TBL] [Abstract][Full Text] [Related]
3. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer. PelvEx Collaborative Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456 [TBL] [Abstract][Full Text] [Related]
5. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases]. Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. van Ramshorst G Colorectal Dis; 2020 Oct; 22(10):1216. PubMed ID: 33099877 [No Abstract] [Full Text] [Related]
7. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer. Harris CA; Solomon MJ; Heriot AG; Sagar PM; Tekkis PP; Dixon L; Pascoe R; Dobbs BR; Frampton CM; Harji DP; Kontovounisios C; Austin KK; Koh CE; Lee PJ; Lynch AC; Warrier SK; Frizelle FA Ann Surg; 2016 Aug; 264(2):323-9. PubMed ID: 26692078 [TBL] [Abstract][Full Text] [Related]
8. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010. Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284 [TBL] [Abstract][Full Text] [Related]
9. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Platt E; Dovell G; Smolarek S Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497 [TBL] [Abstract][Full Text] [Related]
11. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530 [TBL] [Abstract][Full Text] [Related]
12. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer. Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132 [TBL] [Abstract][Full Text] [Related]
14. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer]. Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427 [No Abstract] [Full Text] [Related]
15. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370 [TBL] [Abstract][Full Text] [Related]
16. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma. Quyn AJ; Murthy S; Gould L; Said H; Tiernan J; Sagar P; Antoniou A; Jenkins I; Burns EM Colorectal Dis; 2023 Nov; 25(11):2131-2138. PubMed ID: 37753947 [TBL] [Abstract][Full Text] [Related]
17. Curative pelvic exenteration: initial experience and clinical outcome. Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871 [TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193 [TBL] [Abstract][Full Text] [Related]
19. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085 [TBL] [Abstract][Full Text] [Related]
20. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes. Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]